Roman Nowicki

4.3k total citations
229 papers, 2.4k citations indexed

About

Roman Nowicki is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Roman Nowicki has authored 229 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Dermatology, 65 papers in Epidemiology and 62 papers in Immunology. Recurrent topics in Roman Nowicki's work include Dermatology and Skin Diseases (53 papers), Nail Diseases and Treatments (44 papers) and Cutaneous lymphoproliferative disorders research (39 papers). Roman Nowicki is often cited by papers focused on Dermatology and Skin Diseases (53 papers), Nail Diseases and Treatments (44 papers) and Cutaneous lymphoproliferative disorders research (39 papers). Roman Nowicki collaborates with scholars based in Poland, United States and Italy. Roman Nowicki's co-authors include Małgorzata Sokołowska‐Wojdyło, Bogusław Nedoszytko, Magdalena Trzeciak, Jolanta Gleń, Wioletta Barańska‐Rybak, Katarzyna Rückemann-Dziurdzińska, Aneta Szczerkowska‐Dobosz, Jadwiga Roszkiewicz, Magdalena Lange and Michał Sobjanek and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Roman Nowicki

211 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Nowicki Poland 22 955 732 538 469 345 229 2.4k
Jun Young Lee South Korea 26 875 0.9× 275 0.4× 328 0.6× 193 0.4× 275 0.8× 151 2.0k
Stefanie Eyerich Germany 28 1.3k 1.4× 1.6k 2.2× 245 0.5× 616 1.3× 345 1.0× 59 3.2k
J.‐P. Ortonne France 30 1.5k 1.6× 2.0k 2.8× 360 0.7× 258 0.6× 556 1.6× 69 3.4k
Ayşe Serap Karadağ Türkiye 24 1.1k 1.2× 393 0.5× 272 0.5× 81 0.2× 162 0.5× 204 2.2k
Aurore Rozières France 22 814 0.9× 565 0.8× 197 0.4× 485 1.0× 211 0.6× 59 1.7k
Axel Trautmann Germany 35 1.8k 1.9× 1.0k 1.4× 239 0.4× 1.6k 3.4× 516 1.5× 134 4.1k
John Su Australia 24 981 1.0× 156 0.2× 170 0.3× 773 1.6× 134 0.4× 74 1.8k
Antti Lauerma Finland 31 2.7k 2.9× 1.6k 2.1× 258 0.5× 1.4k 2.9× 471 1.4× 112 4.5k
K. Kalimo Finland 42 2.3k 2.4× 460 0.6× 646 1.2× 2.2k 4.6× 302 0.9× 128 4.6k
Yuumi Nakamura Japan 19 600 0.6× 772 1.1× 155 0.3× 350 0.7× 240 0.7× 46 2.1k

Countries citing papers authored by Roman Nowicki

Since Specialization
Citations

This map shows the geographic impact of Roman Nowicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Nowicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Nowicki more than expected).

Fields of papers citing papers by Roman Nowicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Nowicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Nowicki. The network helps show where Roman Nowicki may publish in the future.

Co-authorship network of co-authors of Roman Nowicki

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Nowicki. A scholar is included among the top collaborators of Roman Nowicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Nowicki. Roman Nowicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaryczańska, Anna, et al.. (2024). Brentuximab Vedotin-induced Tumour Lysis Syndrome in Mycosis Fungoides: A Case Report. Acta Dermato Venereologica. 104. adv41982–adv41982.
2.
Nowicki, Roman, et al.. (2024). Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumab in a breast cancer patient. Frontiers in Pharmacology. 15. 1445685–1445685. 1 indexed citations
3.
Trzeciak, Magdalena, et al.. (2023). Contact Dermatitis to Diabetes Medical Devices. International Journal of Molecular Sciences. 24(13). 10697–10697. 16 indexed citations
4.
Zegarska, Barbara, Lidia Rudnicka, Joanna Narbutt, et al.. (2023). Dermocosmetics in the management of acne vulgaris.Recommendations of the Polish Dermatological Society. Part II. SHILAP Revista de lepidopterología. 110(5). 593–601. 1 indexed citations
5.
Wierzbicki, Piotr, Bogusław Nedoszytko, Małgorzata Sokołowska‐Wojdyło, et al.. (2022). The role of occlusion and micro-incontinence in the pathogenesis of penile lichen sclerosus: an observational study of pro-inflammatory cytokines’ gene expression. International Urology and Nephrology. 54(4). 763–772. 10 indexed citations
6.
Purzycka-Bohdan, Dorota, Roman Nowicki, F. Herms, et al.. (2022). The Pathogenesis of Giant Condyloma Acuminatum (Buschke-Lowenstein Tumor): An Overview. International Journal of Molecular Sciences. 23(9). 4547–4547. 16 indexed citations
7.
Saunte, Ditte Marie Lindhardt, M. Pereiro, Carmen Rodríguez‐Cerdeira, et al.. (2021). Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. Journal of the European Academy of Dermatology and Venereology. 35(7). 1582–1586. 68 indexed citations
8.
Sobjanek, Michał, et al.. (2021). Tattoos Dermatological Complications: Analysis of 53 Cases from Northern Poland. Dermatology. 238(4). 799–806. 4 indexed citations
9.
Rudnicka, Lidia, et al.. (2021). Neonatal lupus erythematosus – practical guidelines. Journal of Perinatal Medicine. 49(5). 529–538. 19 indexed citations
10.
Trzeciak, Magdalena, et al.. (2020). Expression Profiles of Genes Encoding Cornified Envelope Proteins in Atopic Dermatitis and Cutaneous T-Cell Lymphomas. Nutrients. 12(3). 862–862. 19 indexed citations
11.
Wertheim‐Tysarowska, Katarzyna, et al.. (2018). A novel de novo mutation p.Ala428Asp in KRT5 gene as a cause of localized epidermolysis bullosa simplex. Experimental Dermatology. 28(10). 1131–1134. 2 indexed citations
12.
Szczerkowska‐Dobosz, Aneta, Maria Dudziak, Tomasz Zdrojewski, et al.. (2016). Assessment of Cardiovascular Risk Factors in Patients with Psoriasis.. PubMed. 24(4). 261–267. 4 indexed citations
13.
Woźniak, Katarzyna, Marian Dmochowski, Waldemar Placek, et al.. (2016). Pemfigoid - diagnostyka i leczenie Konsensus Polskiego Towarzystwa Dermatologicznego. 103. 1 indexed citations
14.
Sokołowska‐Wojdyło, Małgorzata, Aleksandra G. Florek, Jan Maciej Zaucha, et al.. (2014). Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma. American Journal of Therapeutics. 23(3). e749–e756. 9 indexed citations
15.
Owczarczyk‐Saczonek, Agnieszka & Roman Nowicki. (2013). Pathophysiology of the relationship of psoriasis and metabolic disorders. 100(2). 125–131. 1 indexed citations
16.
Nowicki, Roman. (2010). Leczenie infekcji skóry w atopowym zapaleniu skóry. 4(5). 323–329. 1 indexed citations
17.
Correia, Osvaldo, et al.. (2005). Clinical trial design – towards better practices. Journal of the European Academy of Dermatology and Venereology. 19(s1). 40–42. 3 indexed citations
18.
Nowicki, Roman, et al.. (2004). Jakość życia w chorobach skóry. Przewodnik Lekarza/Guide for GPs. 7(9). 60–65. 5 indexed citations
19.
Samet, Alfred, et al.. (2004). Wpływ leków przeciwbakteryjnych na florę bakteryjną i grzybiczą pochwy. Przewodnik Lekarza/Guide for GPs. 7(5). 92–97.
20.
Samet, Alfred, et al.. (2004). Nosicielstwo Staphylococcus aureus w jamie nosowej jako czynnik ryzyka chorób skóry i zakażeń ogólnoustrojowych. Przewodnik Lekarza/Guide for GPs. 6(9). 28–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Young Lee Breakdown of academic impact, for papers by Stefanie Eyerich Breakdown of academic impact, for papers by J.‐P. Ortonne Breakdown of academic impact, for papers by Ayşe Serap Karadağ Breakdown of academic impact, for papers by Aurore Rozières Breakdown of academic impact, for papers by Axel Trautmann Breakdown of academic impact, for papers by John Su Breakdown of academic impact, for papers by Antti Lauerma Breakdown of academic impact, for papers by K. Kalimo Breakdown of academic impact, for papers by Yuumi Nakamura
Rankless by CCL
2026